NCT05242965: A Multiple Antigen Vaccine (STEMVAC) for the Treatment of Patients With Stage IV Non-Small Cell Lung Cancer |
|
|
| Recruiting | 2 | 40 | US | CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine, CD105/Yb-1/SOX2/CDH3/MDM2 Plasmid Vaccine, STEMVAC, STEMVAC Th1 Polyepitope Plasmid-based Vaccine, Sargramostim, 23-L-Leucinecolony-Stimulating Factor 2, DRG-0012, Leukine, Prokine, rhu GM-CFS, Sagramostim, Sargramostatin, Computed Tomography, CAT Scan, Computed Axial Tomography, CT Scan, Biopsy, Bx, Biospecimen Collection, Biological Sample Collection | University of Washington, United States Department of Defense | Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | 12/25 | 12/26 | | |
Benefit VA, NCT06520098: A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) |
|
|
| Not yet recruiting | 2 | 100 | US | Venetoclax, VENCLEXTA, Ibrutinib, Acalabrutinib, Zanubrutinib, IMBRUVICA, CALQUENCE, BRUKINSA | VA Office of Research and Development | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | 06/30 | 12/30 | | |
